| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
|
Clin Cancer Res
|
2004
|
16.51
|
|
2
|
Gene expression profiling identifies clinically relevant subtypes of prostate cancer.
|
Proc Natl Acad Sci U S A
|
2004
|
10.99
|
|
3
|
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.
|
Proc Natl Acad Sci U S A
|
2005
|
10.85
|
|
4
|
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.
|
PLoS Biol
|
2004
|
9.38
|
|
5
|
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
|
N Engl J Med
|
2016
|
8.53
|
|
6
|
Molecular characterisation of soft tissue tumours: a gene expression study.
|
Lancet
|
2002
|
7.05
|
|
7
|
Diversity, topographic differentiation, and positional memory in human fibroblasts.
|
Proc Natl Acad Sci U S A
|
2002
|
6.98
|
|
8
|
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271.
|
Nature
|
2010
|
5.05
|
|
9
|
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
|
Proc Natl Acad Sci U S A
|
2012
|
4.20
|
|
10
|
Endothelial cell diversity revealed by global expression profiling.
|
Proc Natl Acad Sci U S A
|
2003
|
3.98
|
|
11
|
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells.
|
Proc Natl Acad Sci U S A
|
2009
|
3.87
|
|
12
|
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
|
Am J Pathol
|
2004
|
3.84
|
|
13
|
Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.
|
Sci Transl Med
|
2011
|
3.68
|
|
14
|
Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies.
|
Science
|
2013
|
3.25
|
|
15
|
Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays.
|
Am J Pathol
|
2002
|
3.11
|
|
16
|
A DNA microarray survey of gene expression in normal human tissues.
|
Genome Biol
|
2005
|
2.90
|
|
17
|
Determination of stromal signatures in breast carcinoma.
|
PLoS Biol
|
2005
|
2.84
|
|
18
|
Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.
|
Proc Natl Acad Sci U S A
|
2006
|
2.72
|
|
19
|
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
|
Am J Surg Pathol
|
2008
|
2.68
|
|
20
|
Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray.
|
Am J Pathol
|
2003
|
2.59
|
|
21
|
Gene expression patterns in ovarian carcinomas.
|
Mol Biol Cell
|
2003
|
2.55
|
|
22
|
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis.
|
Mod Pathol
|
2007
|
2.47
|
|
23
|
Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers.
|
Genome Biol
|
2012
|
2.12
|
|
24
|
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.
|
Proc Natl Acad Sci U S A
|
2006
|
2.08
|
|
25
|
The macrophage colony-stimulating factor 1 response signature in breast carcinoma.
|
Clin Cancer Res
|
2009
|
2.00
|
|
26
|
The Stanford Tissue Microarray Database.
|
Nucleic Acids Res
|
2007
|
1.96
|
|
27
|
TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
|
Am J Surg Pathol
|
2007
|
1.94
|
|
28
|
3'-end sequencing for expression quantification (3SEQ) from archival tumor samples.
|
PLoS One
|
2010
|
1.91
|
|
29
|
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss.
|
Mod Pathol
|
2008
|
1.90
|
|
30
|
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma.
|
Proc Natl Acad Sci U S A
|
2012
|
1.86
|
|
31
|
The fibromatosis signature defines a robust stromal response in breast carcinoma.
|
Lab Invest
|
2008
|
1.85
|
|
32
|
A compact VEGF signature associated with distant metastases and poor outcomes.
|
BMC Med
|
2009
|
1.84
|
|
33
|
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.
|
Am J Surg Pathol
|
2012
|
1.83
|
|
34
|
Gene expression in the normal adult human kidney assessed by complementary DNA microarray.
|
Mol Biol Cell
|
2003
|
1.79
|
|
35
|
Stromal responses among common carcinomas correlated with clinicopathologic features.
|
Clin Cancer Res
|
2013
|
1.75
|
|
36
|
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
|
Breast Cancer Res Treat
|
2007
|
1.75
|
|
37
|
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
|
N Engl J Med
|
2015
|
1.75
|
|
38
|
Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections.
|
J Clin Endocrinol Metab
|
2003
|
1.73
|
|
39
|
Prognostic significance of macrophage infiltration in leiomyosarcomas.
|
Clin Cancer Res
|
2008
|
1.73
|
|
40
|
Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma.
|
Clin Cancer Res
|
2004
|
1.67
|
|
41
|
Gene expression patterns in pancreatic tumors, cells and tissues.
|
PLoS One
|
2007
|
1.61
|
|
42
|
Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
|
Mod Pathol
|
2002
|
1.60
|
|
43
|
Three differentiation states risk-stratify bladder cancer into distinct subtypes.
|
Proc Natl Acad Sci U S A
|
2012
|
1.60
|
|
44
|
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.
|
Proc Natl Acad Sci U S A
|
2012
|
1.51
|
|
45
|
Gene expression profiles of cutaneous B cell lymphoma.
|
J Invest Dermatol
|
2003
|
1.51
|
|
46
|
Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections.
|
Mod Pathol
|
2003
|
1.50
|
|
47
|
Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans.
|
Am J Pathol
|
2003
|
1.49
|
|
48
|
Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
|
Am J Surg Pathol
|
2007
|
1.49
|
|
49
|
Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.
|
Am J Pathol
|
2009
|
1.48
|
|
50
|
Gene expression profiling of breast cancer.
|
Annu Rev Pathol
|
2008
|
1.47
|
|
51
|
Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer.
|
PLoS Genet
|
2008
|
1.39
|
|
52
|
Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.
|
Gynecol Oncol
|
2005
|
1.34
|
|
53
|
The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer.
|
Cancer Res
|
2005
|
1.30
|
|
54
|
Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles.
|
Oncogene
|
2004
|
1.30
|
|
55
|
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours.
|
J Pathol
|
2010
|
1.29
|
|
56
|
Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors.
|
Am J Pathol
|
2007
|
1.28
|
|
57
|
Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma.
|
Cancer Res
|
2008
|
1.28
|
|
58
|
A systems biology approach to anatomic diversity of skin.
|
J Invest Dermatol
|
2008
|
1.23
|
|
59
|
Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone.
|
Mod Pathol
|
2008
|
1.22
|
|
60
|
ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
|
J Pathol
|
2012
|
1.21
|
|
61
|
Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers.
|
Virchows Arch
|
2009
|
1.19
|
|
62
|
Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.
|
PLoS Genet
|
2013
|
1.19
|
|
63
|
Novel endothelial cell markers in hepatocellular carcinoma.
|
Mod Pathol
|
2004
|
1.18
|
|
64
|
MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary.
|
PLoS One
|
2009
|
1.18
|
|
65
|
Sox10 and S100 in the diagnosis of soft-tissue neoplasms.
|
Appl Immunohistochem Mol Morphol
|
2012
|
1.15
|
|
66
|
Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
|
Am J Surg Pathol
|
2007
|
1.14
|
|
67
|
The gene expression profile of extraskeletal myxoid chondrosarcoma.
|
J Pathol
|
2005
|
1.13
|
|
68
|
CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.
|
Am J Pathol
|
2011
|
1.12
|
|
69
|
Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans.
|
Am J Surg Pathol
|
2004
|
1.12
|
|
70
|
The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
|
Am J Surg Pathol
|
2012
|
1.09
|
|
71
|
Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology.
|
Am J Pathol
|
2003
|
1.07
|
|
72
|
Gene expression programs of human smooth muscle cells: tissue-specific differentiation and prognostic significance in breast cancers.
|
PLoS Genet
|
2007
|
1.07
|
|
73
|
Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth.
|
Proc Natl Acad Sci U S A
|
2013
|
1.06
|
|
74
|
Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.
|
PLoS One
|
2011
|
1.03
|
|
75
|
A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer.
|
PLoS One
|
2011
|
1.03
|
|
76
|
DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies.
|
Appl Immunohistochem Mol Morphol
|
2010
|
1.01
|
|
77
|
Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred.
|
J Clin Oncol
|
2005
|
0.99
|
|
78
|
Variations in stromal signatures in breast and colorectal cancer metastases.
|
J Pathol
|
2010
|
0.99
|
|
79
|
CDX2 is an amplified lineage-survival oncogene in colorectal cancer.
|
Proc Natl Acad Sci U S A
|
2012
|
0.99
|
|
80
|
Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data.
|
Mod Pathol
|
2007
|
0.98
|
|
81
|
hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature.
|
Am J Surg Pathol
|
2008
|
0.98
|
|
82
|
TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays.
|
Mod Pathol
|
2005
|
0.98
|
|
83
|
A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors.
|
Mod Pathol
|
2009
|
0.97
|
|
84
|
Modeling clear cell sarcomagenesis in the mouse: cell of origin differentiation state impacts tumor characteristics.
|
Cancer Cell
|
2013
|
0.96
|
|
85
|
Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
|
Am J Surg Pathol
|
2008
|
0.96
|
|
86
|
The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms.
|
Mod Pathol
|
2007
|
0.96
|
|
87
|
High-resolution array-based comparative genomic hybridization for distinguishing paraffin-embedded Spitz nevi and melanomas.
|
Diagn Mol Pathol
|
2004
|
0.96
|
|
88
|
Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
|
Hum Pathol
|
2009
|
0.96
|
|
89
|
SMURF1 amplification promotes invasiveness in pancreatic cancer.
|
PLoS One
|
2011
|
0.94
|
|
90
|
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer.
|
J Clin Invest
|
2016
|
0.92
|
|
91
|
Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target.
|
J Pathol
|
2011
|
0.91
|
|
92
|
Experimental approaches to the study of cancer-stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis.
|
Lab Invest
|
2007
|
0.90
|
|
93
|
Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
|
Am J Surg Pathol
|
2011
|
0.86
|
|
94
|
Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST].
|
PLoS One
|
2013
|
0.85
|
|
95
|
Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value.
|
Histopathology
|
2015
|
0.85
|
|
96
|
Expression of FKBP12 in benign and malignant vascular endothelium: an immunohistochemical study on conventional sections and tissue microarrays.
|
Am J Surg Pathol
|
2003
|
0.85
|
|
97
|
Desktop transcriptome sequencing from archival tissue to identify clinically relevant translocations.
|
Am J Surg Pathol
|
2013
|
0.85
|
|
98
|
Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
|
Am J Clin Pathol
|
2008
|
0.84
|
|
99
|
Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer.
|
Breast Cancer Res
|
2013
|
0.83
|
|
100
|
Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma.
|
Sarcoma
|
2012
|
0.83
|
|
101
|
Flipping the script on macrophages in leiomyosarcoma.
|
Oncoimmunology
|
2012
|
0.82
|
|
102
|
Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes.
|
Clin Cancer Res
|
2010
|
0.82
|
|
103
|
A novel method for making "tissue" microarrays from small numbers of suspension cells.
|
Appl Immunohistochem Mol Morphol
|
2005
|
0.82
|
|
104
|
Screening of tissue microarrays for ubiquitin proteasome system components in tumors.
|
Methods Enzymol
|
2005
|
0.81
|
|
105
|
Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation.
|
BMC Cancer
|
2010
|
0.80
|
|
106
|
Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue.
|
Mod Pathol
|
2008
|
0.79
|
|
107
|
Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
|
J Surg Oncol
|
2015
|
0.78
|
|
108
|
Other targetable sarcomas.
|
Semin Oncol
|
2009
|
0.78
|
|
109
|
Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumors.
|
Oncoimmunology
|
2013
|
0.77
|
|
110
|
The prognostic value of tumor-associated macrophages in leiomyosarcoma: a single institution study.
|
Am J Clin Oncol
|
2011
|
0.76
|
|
111
|
Stromal responses among carcinomas--response.
|
Clin Cancer Res
|
2014
|
0.75
|
|
112
|
Ossifying fibromyxoid tumor of soft parts presenting as a scalp cyst.
|
J Cutan Pathol
|
2006
|
0.75
|
|
113
|
Immunohistochemical and biogenetic features of diffuse-type tenosynovial giant cell tumors: the potential roles of cyclin A, P53, and deletion of 15q in sarcomatous transformation.
|
Clin Cancer Res
|
2008
|
0.75
|
|
114
|
Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma.
|
Appl Immunohistochem Mol Morphol
|
2005
|
0.75
|
|
115
|
PAX7 Expression in Rhabdomyosarcoma, Related Soft Tissue Tumors, and Small Round Blue Cell Neoplasms.
|
Am J Surg Pathol
|
2016
|
0.75
|
|
116
|
Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.
|
Mod Pathol
|
2016
|
0.75
|